CD44 antigen is a transmembranous glycoprotein (80 kDa) antibody that is specific for epitope 3 of the CD44 H molecule, CD44 (HCAM) is a cell adhesion molecule that plays an important role in the cascade of metastasis and progression of human malignant tumours. CD44 antigen is present on T lymphocytes, granulocytes, red blood cells, brain and epithelial cells. The standard isoform, CD44s, are also expressed in a wide range of normal tissures such as tonsil, skin, bladder and cervical squamous epithelium. In breast cancer studies, CD44 expression, as assessed by immunohistochemical staining demonstrated a favorable prognostic factor in patients with node-negative invasive breast carcinoma, Further studies have shown a subpopulation of CD44+/CD24- in breast cancer cells have stem/progenitor cell properties.
The CD44 predilute (PM 380) is tittered specifically for use in bladder cancer (see image below). It may be used an optional step with the Uro-2™ (CK20 + p53) Multiplex Cocktail (API 3001DS).
![Reactive atypia in bladder stained with CD44 [Bajoran Purple Chromogen]. Reactive atypia in bladder stained with CD44 [Bajoran Purple Chromogen].](http://biocare.net/wp-content/uploads/380-1.jpg)
Reactive atypia in bladder stained with CD44 [Bajoran Purple Chromogen].
| Specifications | |
|---|---|
| Intended Use | IVD |
| Source | Mouse Monoclonal |
| Species Reactivity | Human, Others not tested |
| Clone | BC8 |
| Isotype | IgG2a |
| Antigen | CD44 |
| Cellular Localization | Cell membrane, Cytoplasmic |
| Positive Control | Breast Cancer, Tonsil |
| Normal Tissue | Tonsil |
| Abnormal Tissue | Breast, Esophageal cancer |
| Ordering Information | Catalog Number | Volume |
|---|---|---|
| Concentrate | CM 380 | B |
| Predilute | PM 380 | AA |
| intelliPATH™ | N/A | N/A |
| VP Echelon | N/A | N/A |
| A / AK = 0.1 ml | B / BK = 0.5 ml | C / CK = 1.0 ml | G5 = 5.0 ml | AA = 6.0 ml | H / G25 = 25 ml | L = 100 ml |
|---|
| Data Sheets |
|---|
| Download Data Sheet |